DiscoveryPak™

A convenient set containing 8 antiviral agents for developing drugs against COVID-19 as shown in the table below.Alternate Name/Synonyms: Antiviral Agents Multipack, Antiviral Agents Research...

A convenient set containing nine (9) RAF kinase inhibitors. The set contains 25 mg of BAY 43-9006 mesylate (Cat. No. 1594); 5 mg of Encorafenib (Cat. No. B2103); 5 mg of GSK-2118436 mesylate (Cat. No...

A convenient set of 8 (eight) small molecule GSK-3 inhibitors for research.Alternate Name/Synonyms: Appearance: N/AAppearance: N/AAppearance: See under individual productsAppearance: See under...

A convenient set of 9 (nine) small molecule JAK inhibitors for research.Alternate Name/Synonyms: Appearance: N/AAppearance: N/AAppearance: See under individual productsAppearance: See under...

DiscoveryPak™ Neuronal Cell Induction Small Molecules Set is a convenient set containing eight small molecules useful for induction of neuronal cells (hciNs) from human fibroblasts. The eight...

A convenient set of six small molecule modulators (V6CTFZ) useful for generation of iPSC’s (induced pluripotent stem cells) from mouse somatic cells. The six modulators are: 200 mg of Valproic acid...

DiscoveryPak™ Epigenetic Modulators Set II is a convenient set of ten (10) small molecule modulators useful in epigenetics research. Each set contains 5 mg of AMI-1 (Cat. No. 1943-5), 10 mg of...

DiscoveryPak™ Epigenetic Modulators Set I is a convenient set of ten (10) small molecule modulators useful in epigenetics research. Each set contains 5 mg of Anacardic acid (Cat. No. 1849-5), 5 mg of...

A convenient set of ten small molecules useful for enhancing the reprogramming efficiency. The ten products are: 5 mg of (±) –Bay K 8644 (Cat. No. 1682-5), 5 mg of BIX01294 (Cat. No. 1678-5), 5 mg of...

A convenient set of five small molecules useful for self-renewal in stem cells and induced pluripotent stem cells (iPSCs). The five products are: 1 mg of A-83-01 (Cat. No. 1725-1), 5 mg of CHIR99021...

A convenient set consisting of eight Receptor Tyrosine Kinase (RTK) inhibitors. The eight inhibitors are: 5 mg of Axitinib (Cat. No. 1581-5), 5 mg of Canertinib (Cat. No. 1617-5), 5 mg of Gefitinib...